Characteristics of “super responders” and “super nonresponders” to first biologic monotherapy for psoriasis: a nested case-control study
BJD, 2023.
Kayleigh J. Mason, Oras A. Alabas, Nick Dand, Richard B. Warren, Nick J. Reynolds, Jonathan N.W.N. Barker, Zenas Z. N. Yiu, Catherine H. Smith, Christopher E.M. Griffiths, the BADBIR Study Group.
Read publication: BJD
Related
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-b...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
0 Comments